Great Valley Advisor Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419K Sell
1,084
-246
-18% -$91.2K 0.01% 770
2026
Q1
$390K Sell
1,330
-764
-36% -$251K 0.01% 754
2025
Q4
$734K Sell
2,094
-139
-6% -$47K 0.01% 540
2025
Q3
$722K Sell
2,233
-996
-31% -$310K 0.01% 548
2025
Q2
$1.26M Sell
3,229
-260
-7% -$105K 0.03% 418
2025
Q1
$1.52M Sell
3,489
-428
-11% -$172K 0.03% 367
2024
Q4
$1.45M Sell
3,917
-122
-3% -$51.1K 0.03% 373
2024
Q3
$2.1M Sell
4,039
-67
-2% -$35.8K 0.05% 300
2024
Q2
$2.23M Sell
4,106
-997
-20% -$527K 0.06% 271
2024
Q1
$2.65M Buy
5,103
+63
+1% +$31.3K 0.08% 232
2023
Q4
$2.38M Sell
5,040
-498
-9% -$230K 0.08% 216
2023
Q3
$2.41M Buy
5,538
+115
+2% +$52.2K 0.1% 199
2023
Q2
$2.41M Sell
5,423
-992
-15% -$458K 0.1% 200
2023
Q1
$2.95M Sell
6,415
-1,501
-19% -$714K 0.14% 171
2022
Q4
$4.06M Sell
7,916
-354
-4% -$180K 0.21% 117
2022
Q3
$3.76M Sell
8,270
-1,460
-15% -$699K 0.21% 120
2022
Q2
$4.7M Buy
+9,730
New +$4.81M 0.26% 98

Other funds holding ELV

Great Valley Advisor Group's ELV Position: Q2 2026 in Review

Great Valley Advisor Group reduced its Elevance Health (ELV) stake by 18% in Q2 2026, selling an estimated $91.2K and leaving 1,084 shares worth $419K. The position accounts for 0.01% of the portfolio, ranked #770.

Great Valley Advisor Group first reported a position in ELV in Q2 2022 and has held it in 17 quarters since. The position peaked at $4.7M in Q2 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Great Valley Advisor Group held 1,084 shares of Elevance Health worth $419K as of Q2 2026.
  • Great Valley Advisor Group sold 246 Elevance Health shares in Q2 2026, an estimated $91.2K.
  • Elevance Health made up 0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #770 holding.
  • Great Valley Advisor Group first reported a position in Elevance Health in Q2 2022 and has held it in 17 quarters since.
  • Great Valley Advisor Group's Elevance Health position peaked at $4.7M in Q2 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.